- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 2nd, 2007
Small-cap bio-nanotech company pSivida (PSDV - Cramer's Take - Stockpickr) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE - Cramer's Take - Stockpickr - Rating).
It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.
|Related News Press|
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Better battery imaging paves way for renewable energy future April 20th, 2015
Quantum model reveals surface structure of water: National Physical Laboratory, IBM and Edinburgh University have used a new quantum model to reveal the molecular structure of water's liquid surface April 20th, 2015
Nondestructive 3-D Imaging of Biological Cells with Sound April 20th, 2015